Skip to main content
MYOHealthcare

Myomo Inc (MYO) Insider Trading

In the last 90 days, 2 Myomo Inc (MYO) insiders reported no open-market purchases and 3 sales totaling $70,730. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 11, 2026Harry KovelmanChief Medical OfficerSale15,488$1.27$19,684
Sep 2, 2026Milton Mayo MorrisDirectorSale15,000$1.41$21,150
Aug 20, 2026Harry KovelmanChief Medical OfficerSale17,250$1.73$29,896
Jun 5, 2026Thomas F KirkDirectorOpen Market Purchase40,002$1.27$50,803
May 28, 2026Thomas F KirkDirectorOpen Market Purchase25,000$0.99$24,825
May 28, 2026Harry KovelmanChief Medical OfficerSale32,000$1.01$32,240
May 18, 2026Thomas F KirkDirectorOpen Market Purchase75,006$0.91$68,240
May 15, 2026Joseph M. Manko Jr.Corporate insiderOpen Market Purchase201,197$0.86$173,915
May 14, 2025Micah MitchellChief Commercial OfficerSale90,231$0.86$77,689

Common questions

MYO insider trading FAQ

Are MYO insiders buying or selling?
Over the last 90 days, MYO insiders were net sellers, reporting $0.00 of open-market purchases and $70,730 of sales.
When was the last MYO insider purchase?
No open-market insider purchase of Myomo Inc stock was reported in the last 90 days.
Where does MYO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Myomo Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.